Unfortunately, war is the daily media lead. We get the numbers of dead and injured for each conflict. You might consider those just injured as ‘lucky’ if you’re like me. Au contraire. Familiar issues are traumatic brain and spine injuries. Alongside lost limbs and wounds caused by bomb debris and emotional symptoms such as PTSD and depression that may persist for years, sometimes a lifetime. (Xaigham.com)
For life-saving technologies, war has unfortunately become a growth sector. I take no pleasure in saying that.
A sudden, traumatic blow to the spine (tSCI) can fracture, dislocate, crush or compress one or more of the vertebrae. A gunshot or knife wound that penetrates and cuts the spinal cord also can cause a spinal cord injury. Additional damage usually occurs over days or weeks.
The global Spinal Cord Trauma Treatment market was valued at US$ 2458.9 million in 2022 and is projected to reach US$ 3009.4 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The current Middle East conflict was not included. Unfortunately, those projected growth numbers could rise significantly.
While I am using the wars and conflicts as examples of the growth of the traumatic injury market, it was already significant and this is just the US.
The question arises: how is this issue addressed? There are myriad companies, large and small, looking for answers.
TORONTO and HAIFA, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries.
How does it work? Stay with me; it’s pretty straightforward.
Part One: Active Ingredients
Exosomes: Exosomes, also known as extracellular vesicles, are nano-sized, naturally occurring particles in the body, secreted by cells. Exosomes, also known as extracellular vesicles, are nano-sized, naturally occurring particles in the body, secreted by cells. Can be administered non-invasively, intranasally
Part Two: Delivery
ExoTherapy: Exosomes, loaded with therapeutic molecules, cross the blood-brain barrier and reach cells and tissues for regeneration, rewiring and recovery.
Part Three: Effect
SiRNA-PTEN: The suggested PTEN inhibition-based therapeutic targets are nerve growth and regeneration after injury or damage, treatment of cardiac ischemia/reperfusion and associated disease, wound repair, and infertility.
The goal is to reverse this traumatic brain trauma as well as develop other health issues such as depression—no small accomplishment. The US FDA has granted NRX Orphan Drug Status.
The Orphan Drug Designation program provides orphan status to drugs and biologics for rare diseases that meet specific criteria. Orphan drug designation provides incentives, including:
“Orphan-drug designation is expected to streamline our go-to-market, shorten our regulatory process, save the Company millions of dollars, and provide valuable market exclusivity. We appreciate the formal recognition of the potential impact of our therapy on the lives of patients suffering from acute spinal cord injuries,” said Dr. Shaltiel, CEO of NurExone Biologic, Ltd.
The Company also holds an exclusive worldwide license from Technion and Tel Aviv University for developing and commercializing the technology.
This technology is not only promising but appears well destined for success. In their totality, the current NRX out-front therapies could bring much relief to those seriously ‘injured’ patients who live with chronic pain and myriad challenges daily.
NurExome is a cutting-edge medical technology company. While trading has been modest, it paints a positive investment picture for the previously reasons stated. Will it pop tomorrow? No. That I can guarantee.
A savvy plan would to be to approach as a dollar-cost average investment. The deeper you dig, the more potential will become apparent.
Note Hyperlinks below.
Stock stats Jan 5 2024 | |
52 Week Range | 0.1000 0.4200 |
Volume | 7,000 |
Avg. Volume | 4,511 |
Market Cap | 14.475M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.01 |
In-depth Corporate Presentation Litchfield Research |
August 26
Marc CHALLANDE
If the mid-1990s saw the introduction of online payments (The Stanford Federal Credit Union is credited as the first organization to offer its clients an online payment system), the sector witnessed tremendous growth with Covid-19, which pushed regular consumers to buy online. If the pandemic is weakening, online payments remain, and the market keeps growing. It represents an investment opportunity, and many small-cap companies could become essential players in this industry.
The online payment sector will interest you if you are looking for a market with an “endless” growth opportunity. With the Covid-19 pandemic reducing human interactions, consumers found their happiness online, and online payments became a regular habit, first during the lockdowns and then in our day-to-day lives. Both companies and consumers saw in this technology the opportunity to save time by buying/selling online. According to many surveys, online payments should constitute a more prominent aspect of our buying routine. Another important data is digitalization is boosting the payment market. Smartphones and high penetration of internet connectivity buoy the demand for mobile payment transactions.
The global online payment market was valued at $3,286.52 B in 2019 & is projected to reach $17,643.35 B by 2027, at a CAGR of 23.7% in the forecast period.
Future catalysts will occur in the sector, including incorporating Artificial Intelligence to increase the transactional volume and enhance payment processing. Governments are also pushing these platforms to augment security and transparency, reducing corruption and fraudulent activities. For example, India’s government saved almost USD $8.8B by adopting the online banking payment mode in its fuel subsidy program during 2013-2020.
Among many competitors, Readen Holding reveals to be an underdog in the industry. The company has decided to pursue an investment strategy focusing on payment, e-commerce, and supporting infrastructure technologies. The company acquired OkePay in 2021, a go-to solution for all online payment needs. Okepay is a payment solution that enables a merchant to accept all payment methods supported by an easy integration process. The company also owns OkeApp, an intercompany of OkePay, which helps participating merchants incur no direct payment fees. Merchants benefit from above- and below-the-line marketing campaigns provided by OkeApp. On August 3, RHCO announced a new development of OkeApp. The company launched Oke Travel Club. This development is a worldwide selection of travel-related services and products designed to offer OkeApp members significant price reductions on all travel needs globally. The membership program will provide a selection of 1 million+ locations of hotel and resorts, 205,000+ retail shops, 60,000+ restaurants, 45,000+ car rentals, 500+ airlines and 50+ major cruise lines.
If the company’s products are great, its revenues are even better, as shown in the previous quarter. Readen Holding’s financials kept improving, with a 634% increase quarter-over-quarter (2022/03/31 financial statement). The company even reported a shallow income of $66K. These positive revenues were carried by the ongoing development of OkeApp and the increased revenue in Readies. RHCO also mentioned that its Fintech division, including OkePay, OkeApp, and Readies, has recorded a 700% revenue gain in January 2022 compared to December 2021. January’s revenue approximately equaled the division’s total revenue in the last six months of 2021.
On August 26, the company shared its improved financials for the period ending June 30, proving the company is headed toward the right direction. Readen Holding’s revenue was up 283% compared to 2021 and achieved impressive Earnings from Operation, up 25% year-over-year. The company has, however, reported a loss in Net Profit due to the underperformance of the share price in Tianrong Medical Group, Inc. (OTC: TNMD). The company ramps up pretty fast and should outperform in Q4 2022 with the full launch of OkeApp, and the Angelo Mermer investment.
E-commerce and Retails section of RHCO is also welcoming a bright future, with both Neckermann Direct and Two Percent are fully operating. RHCO has successfully transformed the 90 years old retail brand Neckermann into a B2C E-commerce Platform, and it is bringing Asian products to European customers.
Quote from Readen Holding financial statement.
Readen Holding (RHCO) announced on August 24 multiple amendments to previous transactions. To give some retrospect, the company acquired early 2021 64 acres of the prime real estate alongside the Rhone River in France and planned to develop 690 houses, villas, and apartments for sale and lease. To complete this transaction, the purchase price was 15M shares of RHCO common stocks. Due to multiple tax and legal issues, the selling party failed to deliver the required documents for constructing permission. Nevertheless, Readen Holding has found a positive outlook. The company has agreed with Angelo Mermer (Turkey’s largest holder of marble reserves) to sell the real estate. The transaction is worth EU $2M and was converted to a 50% discount into 200 shares of Angelo Mermer (5% of total Angelo Mermer shares) and is worth approximately USD $5M, according to Baker Tilly.
Despite the cancellation of the real estate acquisition, RHCO has honored the deal with ANGELO MERMER. Instead of real estate, RHCO has paid ANGELO MERMER with 15 million shares of RHCO common stocks restricted. RHCO now has the right to handle the sales and export of ANGELO MERMER’s raw onyx marble blocks into China. Such exporting operations have started recently, with marble blocks being sold and shipped to China and Italy.
“Even though the real estate deal did not work out, we have full confidence in our investment in ANGELO MERMER. That’s why we want to continue to work with ANGELO MERMER. With Turkey’s currency and liquidity crisis, we realize the opportunity to minimize the cost of marble export, thus increasing the profit margin on the export of the products. Trading onyx marble to China would bring us sizable profit for years to come.”
Richard Klitsie, CEO
The Online Payment market is expected to grow at a CAGR of 23.7 to reach $17,643.35 Bn by 2027;
Readen Holding (OTC: RHCO) has recorded a 700% revenue gain in January 2022 compared to December 2021;
The company generates profits;
RHCO honored its deal with Angelo Mermer and has the right to handle the sales and export of ANGELO MERMER’s raw onyx marble blocks into China.
Marc has been involved in the Stock Market Media Industry for the last +4 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website. He then contributed to building Guerilla Capital, a Capital Markets company and FirstPhase Media where he is head of research. At10xAlerts, he writes articles and conducts interviews on many sectors, including technology, metals & mining markets.
©2024 10xAlerts